Zobrazeno 1 - 10
of 81
pro vyhledávání: '"MCLEAN, SAM"'
Autor:
Mclean, Sam
Publikováno v:
RSA Journal, 2011 Oct 01. 157(5547), 42-44.
Externí odkaz:
https://www.jstor.org/stable/41380118
Autor:
Mclean, Sam
Publikováno v:
RSA Journal, 2009 Dec 01. 155(5540), 38-41.
Externí odkaz:
https://www.jstor.org/stable/41379979
Autor:
Jameson, Adam, Tomlinson, Justine, Medlinskiene, Kristina, Dane, Howard, Saeed, Imran, Sohal, J., Dalton, C., Sagoo, G.S., Cardno, A., Bristow, Greg C., Fylan, Beth, McLean, Samantha
Yes
Pharmacogenomic (PGx) testing can help personalise psychiatric prescribing and improve on the currently adopted trial-and-error prescribing approach. However, widespread implementation is yet to occur. Understanding factors influencing imple
Pharmacogenomic (PGx) testing can help personalise psychiatric prescribing and improve on the currently adopted trial-and-error prescribing approach. However, widespread implementation is yet to occur. Understanding factors influencing imple
Externí odkaz:
http://hdl.handle.net/10454/20036
Yes
Background: Presently, there is limited guidance on the maximal dosing of psychosis drugs that is based on effectiveness rather than safety or toxicity. Current maximum dosing recommendations may far exceed the necessary degree of dopamine D
Background: Presently, there is limited guidance on the maximal dosing of psychosis drugs that is based on effectiveness rather than safety or toxicity. Current maximum dosing recommendations may far exceed the necessary degree of dopamine D
Externí odkaz:
http://hdl.handle.net/10454/19916
Autor:
Jameson, Adam, Faisal, Muhammad, Fylan, Beth, Bristow, Greg C., Sohal, J., Dalton, C., Sagoo, G.S., Cardno, A.G., McLean, Samantha
Yes
Background: Prescribing drugs for psychosis (antipsychotics) is challenging due to high rates of poor treatment outcomes, which are in part explained by an individual’s genetics. Pharmacogenomic (PGx) testing can help clinicians tailor the
Background: Prescribing drugs for psychosis (antipsychotics) is challenging due to high rates of poor treatment outcomes, which are in part explained by an individual’s genetics. Pharmacogenomic (PGx) testing can help clinicians tailor the
Externí odkaz:
http://hdl.handle.net/10454/19915
Autor:
Jameson, A., Fylan, Beth, Bristow, Greg C., Cardno, A., Dalton, C., Sagoo, G., Sohal, J., McLean, Samantha
Yes
Patients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.
Patients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.
Externí odkaz:
http://hdl.handle.net/10454/19587
Autor:
Yun, Haesung, Dumbell, R., Hanna, Katie, Bowen, Junior, McLean, Samantha, Kantamneni, Sriharsha, Pors, Klaus, Wu, Q-F, Helfer, Gisela
Yes
Chemerin is an adipokine involved in inflammation, adipogenesis, angiogenesis and energy metabolism, and has been hypothesized as a link between obesity and type II diabetes. In humans affected by obesity, chemerin gene expression in periphe
Chemerin is an adipokine involved in inflammation, adipogenesis, angiogenesis and energy metabolism, and has been hypothesized as a link between obesity and type II diabetes. In humans affected by obesity, chemerin gene expression in periphe
Externí odkaz:
http://hdl.handle.net/10454/18995
Yes
In many species, seasonal changes in day length (photoperiod) have profound effects on physiology and behavior. In humans, these include cognitive function and mood. Here we investigated the effect of photoperiod and high fat diets on cognit
In many species, seasonal changes in day length (photoperiod) have profound effects on physiology and behavior. In humans, these include cognitive function and mood. Here we investigated the effect of photoperiod and high fat diets on cognit
Externí odkaz:
http://hdl.handle.net/10454/18550
Autor:
Jameson, Adam, Fylan, Beth, Bristow, Greg C., Sagoo, G.S., Dalton, C., Cardno, A., Sohal, J., McLean, Samantha L.
Yes
In psychiatry, the selection of antipsychotics and antidepressants is generally led by a trial-and-error approach. The prescribing of these medications is complicated by sub-optimal efficacy and high rates of adverse drug reactions (ADRs). T
In psychiatry, the selection of antipsychotics and antidepressants is generally led by a trial-and-error approach. The prescribing of these medications is complicated by sub-optimal efficacy and high rates of adverse drug reactions (ADRs). T
Externí odkaz:
http://hdl.handle.net/10454/18618